Partnership
ReWalk Robotics acquires AlterG
ReWalk Robotics acquired AlterG for approximately 9 million in cash, adding AlterG's Anti-Gravity systems (NASA-derived Differential Air Pressure technology) to ReWalk's rehabilitation portfolio. AlterG CEO Charles Remsberg joined ReWalk as Chief Sales Officer.
other · Active · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/rewalk-robotics-acquires-alterg.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/rewalk-robotics-acquires-alterg
- Revision history: /partnerships/rewalk-robotics-acquires-alterg/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
bac81442-1bcf-434e-b81c-ec0bc0f9459d- Type
- other
- Status
- Activeoperating
- Announced
- 2023-08-083.1 years ago
- Start
- 2023-08-113.1 years ago
- Active for
- 3.1 years
Who’s involved
ReWalk Robotics (now Lifeward, Nasdaq: LFWD) develops FDA-cleared wearable robotic exoskeletons for individuals with spinal cord injuries. Founded in 2001 in Israel by Dr. Amit Goffer, the company's ReWalk Personal 6.0 was the first personal [Exoskeleton](/companies/exoskeleton-technologies) to receive FDA clearance for home use. The company also markets the ReStore Exo-Suit for stroke rehabilitation and acquired AlterG's Anti-Gravity systems in 2023.
Off-registry parties
- AlterG · other
Related partnerships
Other deals between the same parties
- ReWalk Robotics x Timwell Corporation strategic investmentReWalk Robotics + Timwell Corporationinvestment2018-03-08operating
Other partnerships of ReWalk Robotics
- ReWalk Robotics x Timwell Corporation strategic investmentReWalk Robotics + Timwell Corporationinvestment2018-03-08operating
Recent partnerships of the same kind
- other—operating
- Indian Motorcycle x Vance and Hines Factory Racing PartnershipVance and Hines Motorsports + Indian Motorcycleother—operating
- other—operating
- cargill x ENOUGHCargill + ENOUGHother—operating
- other—operating
- other—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.